Current Report Filing (8-k)
February 20 2018 - 5:10PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
February 20, 2018
Cross Country Healthcare, Inc.
(Exact name of registrant as specified in
its charter)
|
Delaware
|
|
0-33169
|
|
13-4066229
|
|
|
(State or Other Jurisdiction
|
|
(Commission
|
|
(I.R.S. Employer
|
|
|
of Incorporation)
|
|
File Number)
|
|
Identification No.)
|
|
5201 Congress Avenue, Suite 100B, Boca
Raton, FL 33487
(Address of Principal Executive Office)
(Zip Code)
(561) 998-2232
(Registrant’s telephone number, including
area code)
Not Applicable
(Former name or former address, if changed
since last report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
¨
|
Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant is an emerging
growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company
¨
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act.
¨
Incorporated by reference is a press release issued by the Company
on February 20, 2018 and attached hereto as Exhibit 99.1. This information is being furnished under Item 8.01 and shall not be
deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject
to the liability of such section.
|
Item 9.01
|
Financial Statements and Exhibits.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|
|
CROSS COUNTRY HEALTHCARE, INC.
|
|
|
|
|
|
|
|
|
Dated:
|
February 20, 2018
|
By:
|
/s/ Christopher R. Pizzi
|
|
|
|
|
Name: Christopher R. Pizzi
|
|
|
|
Title: SVP, Chief Financial Officer
|
|
|
|
|
Cross Country Health (NASDAQ:CCRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Cross Country Health (NASDAQ:CCRN)
Historical Stock Chart
From Sep 2023 to Sep 2024